Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tianyin Pharma to Start $3 Million Buyback

publication date: Jan 30, 2009

Tianyin Pharmaceutical, Co. will begin its previously announced $3 million stock repurchase program. Originally, the program was supposed to be completed by the end of January (effectively today), but the program has been extended until the end of June. Tianyin’s shares are currently trading for $1.45. $3 million worth of the company’s stock would be approximately 2 million shares. The company has 15.7 million shares outstanding. More details...

Stock Symbol: (NYSE Alternext: TPI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital